Serum C-reactive protein and nutritional parameters in hemodialysis patients
Abstract
Abstract
Background/Aim. Inflammation is the most important factor in the genesis of vascular complication in the end-stage renal disease. The serum C-reactive protein (CRP) level is a sensitive marker of systemic inflammation as well as a predisposing factor for cardiovascular and all cause mortality in patients on hemodialysis. Albumin is the negative acute phase protein and its synthesis declines during the inflammation. The patients undergoing hemodialysis have a high prevalence of protein-energy malnutrition, due to reduced protein synthesis and increased degradation. The low serum albumin levels in these patients originate from the complex setting of conditions with systemic inflammatory response as a major cause, malnutrition and overhydratation. The aim of this study was to determine the prevalence of elevated CRP levels in the dialysis patients and to analyse its correlation with serum albumin levels and other parameters of nutritional status. Methods. The study included 49 patients on maintenance hemodialysis at the Department of Hemodialysis, Clinic of Nephrology, Military Medical Academy, Belgrade, Serbia. In order to analyse the parameters, the blood samples were taken during the arteriovenous fistula (AVF) puncture and before the second weekly dialyse. The following parameters were determined: serum levels of urea and creatinine before and after the dialysis procedure, CRP, hemoglobin, fasting glycemia, total cholesterol, triglycerides, albumins, iron, glycosylated hemoglobin (HbA1c), fasting insulinemia and C-peptide only before the dialysis. Results. Out of 49 patients on maintenance hemodialysis, 37 (75.5%) were males and 12 (24.5%) females with the average age of 56.04 ± 13.93 years. The average duration of the dialysis treatment was 7.37 ± 5 years. The high serum CRP levels (more than 3 mg/L) was found in 65.3% of patients. Singificantly more diabetic patients were observed in the group with the higher CRP levels (n = 12) compared to the group with the normal CRP levels (n = 3) (p ≤ 0.05). A significant positive correlation was found between the CRP value and urea values after the dialysis procedure. We found negative correlation between the CRP values and serum albumin, HbA1c, total cholesterol and triglyceride levels, with no statistical significance. Conclusion. Our study observed a high rate of inflammation in the dialysis patients presenting as high frequency of the elevated CRP levels in the examined group. Negative correlation between CRP levels and serum albumin as well as with some other parameters of nutritional status, suggests that chronic inflammation may be the missing link that actually connect protein energy malnutrition with high morbiditiy and mortality rate in these patients.
References
REFERENCES
Singh SK, Suresh MV, Voleti B, Agrawal A. The connection be-tween C-reactive protein and atherosclerosis. Ann Med 2008; 40(2): 110–20.
Nand N, Agaral HK, Yadav RK, Gupta A, Sharma M. Role of high sensitivity CRP as a marker of inflammation in pre dialy-sis patients. JIACM 2009; 10(1–2): 18–22.
Bazeley J, Bieber B, Li Y, Morgenstern H, Sequera P, Combe C, et al. C-reactive protein and prediction of 1-year mortality in prevalent hemodialysis patients. Clin J Am Soc Nephrol 2011; 6(10): 2452–61.
Rashidi AA, Soleimani AR, Nikoueinejad H, Sarbolouki S. The evaluation of increase in hemodialysis frequency on C-reactive protein levels and nutritional status. Acta Med Iran 2013; 51(2): 119–24.
Daugirdas JT, Blake PG. Handbook of Dialysis. 5th ed. Phila-delphia: Wolters Kluver; 2015.
Stenvinkel P. Inflammation in end-stage renal disease: the hid-den enemy. Nephrology (Carlton) 2006; 11(1): 36–41.
Ates K, Yilmaz O, Kutlav S, Ates A, Nergizoglu G, Erturk S. Se-rum C reactive protein level is associated with renal function and it affects edhocardiographic cardiovascualr disease in pre-dialysis patients. Nephron Clin Pract 2005; 101(4): c190–7.
Schwedler S, Guderian F, Dammrich J, Potempa LA, Wanner C. Tubular staining of modified C-reactive protein in diabetic chronic kidney disease. Nephrol Dial Transplant 2013; 18(11): 2300–7.
Iseki K, Tozawa M, Yoshi S, Fukiyama K. Serum C-reactive pro-tein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant 1999; 14(8): 1956–60.
Krane V, Winkler K, Drechsler C, Lilienthal J, März W, Wanner C. German Diabetes and Dialysis Study Investigators. Associa-tion of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 di-abetes mellitus. Am J Kidney Dis 2009; 54(5): 902–11.
Heidari B. C-reactive protein and other markers of inflamma-tion in hemodialysis patients. Caspian J Intern Med 2013; 4(1): 611–6.
Razeghi E, Parkhideh S, Ahmadi F, Khashayar P. Serum CRP le-vels in pre-dialysis patients. Ren Fail 2008; 30(2): 193–8.
Abraham G , Sundaram V, Sundaram V, Mathew M, Leslie N, Sathiah V. C-reactive protein, a valuable predictive marker in chronic kidney disease. Saudi J Kidney Dis Transpl 2009; 20(5): 811–5.
Nath I, Nath CK, Baruah M, Pathak M, Banerjee R, Goyal S. A Study of Inflammatory Status in J Clin Diagn Res 2013; 7(10): 2143–5.
Rao P, Reddy GC, Kanagasabapathy AS. Malnutrition-inflammation-atherosclerosis syndrome in chronic kidney disease. Indian J Clin Biochem 2008; 23(3): 209–17.
Hecking E, Bragg-Gresham JL, Rayner HC, Pisoni RL, Andreucci VE, Combe C, et al. Hemodialysis prescription, adherence and nutritional indicators in five European countries: Results from the Dialysis and Practice Patterns Study (DOPPS). Nephrol Dial Trnasplant 2004; 19(1): 100–7.
López-Gómez JM, Villaverde M, Jofre R, Rodriguez-Benítez P, Pérez-García R. Interdialytic weight gain as a marker of blood pressure, nutrition, and survival in hemodialysis patients. Kidney Int Suppl 2005; (93): S63–8.
Galland R, Traeger J, Arkouche W, Cleaud C, Delawari E, Fouque D. Short daily hemodialysis rapidly improves nutritional status in hemodialysis patients. Kidney Int 2001; 60(4): 1555–60.
Pecoits-Filho R, Heimbürger O, Bárány P, Suliman M, Fehrman-Ekholm I, Lindholm B, et al. Associations between circulating inflammatory markers and residual renal function in CRF pa-tients. Am J Kidney Dis 2003; 41(6): 1212–8.
Nishizawa Y, Shoji T, Kakiya R, Tsujimoto Y, Tabata T, Ishimura F, et al. Non-high-density lipoprotein choelsterol (non-HDL-C) as a predictor of cardiovascualr mortality in patients with end-stage renal disease. Kidney Int Suppl 2003; (84): S117–20.
NKF KDOQI guidelines: KDOQI clinical practice guideline for cardiovascular disease in hemodialysis patients. Available from:
https://www2.kidney.org/.../kdoqi/guidelines_cvd/guide12.ht
Hayashino Y, Mashitani T, Tsuji S, Ashii H. Serum high-sensitivity C-reactive protein levels are associated with high risk of development, non proression, of diabetic nephropathy among Japanese type 2 diabetic patinets: A prospective cohort study Diabetes Distress and Care Registry at Tenri [DDCRT7. Diabetes Care 2014; 37(11): 2947–52.
Ogita M, Funayama H, Nakamura T, Sakakura K, Sugawara Y, Kubo N, et al. Plaque characterization of non-culprit lesions by virtual histology intravascular ultrasound in diabetic patients: Impact of renal function. J Cardiol 2009; 54(1): 59–65.